What does it take to tackle the risks and issues surrounding drug diversion compliance?

Ed Holmes (ed.holmes@fairwarning.com) is chief executive officer at FairWarning in Clearwater, FL.

In the healthcare industry, 10%–15% of healthcare workers will misuse medication during their career.[1] Unfortunately, the real number is likely even higher because it is extremely difficult to quantify exactly how many incidents there truly are in a hospital setting. Double-digit diversion numbers coupled with incidents that fall through the cracks show that drug diversion is an enormous issue and a risk to patient safety, delivery of care, and compliance. Noncompliance with drug diversion regulations can lead to heavy fines and reputational damage. During the COVID-19 pandemic, this is a recipe for disaster, with hospitals in the US losing an estimated $200 billion by the end of June 2020.[2] The first line of defense in stopping drug diversion is to set up a drug diversion monitoring program.

Traditionally, drug diversion monitoring is a time-consuming and manual process, but today, with access to technology, it’s easier to tackle. As regulations continue to evolve in support of better patient care and medication controls, hospitals need diversion monitoring programs to comply with state and federal laws and guidelines. When adopting such a program, compliance professionals should ensure it includes proper controls for compliance while reducing the risks to patients, staff, and hospital operations. By also selecting technology that supports tracking the flow of medications, healthcare systems can proactively work toward monitoring 100% of transactions.

This document is only available to members. Please log in or become a member.
 


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field